TEK Antibody

What is the TEK receptor and why is it significant in research?

TEK (also called TIE2) is a receptor tyrosine kinase expressed almost exclusively in endothelial cells. Its significance lies in:

• Critical role in endothelial cell-smooth muscle cell communication in venous morphogenesis

• Association with inherited venous malformations

• Function in embryonic vascular development through angiopoietin-1 binding

• Role in maintaining hematopoietic stem cells (HSCs) in a quiescent and antiapoptotic state

The TEK signaling pathway is particularly important in understanding vascular development, angiogenesis, and endothelial cell biology, making TEK antibodies valuable tools in cardiovascular, oncology, and developmental biology research.

What types of TEK antibodies are commercially available and what are their key applications?

A variety of TEK antibodies are available with different characteristics:

When selecting an antibody, consider:

• The application requirements (WB, IHC, ELISA, etc.)

• The species you're studying

• Whether you need general TEK detection or phosphorylation-specific detection

• Monoclonal for consistent, defined epitope recognition versus polyclonal for broader epitope detection

What are the optimal protocols for using TEK antibodies in immunohistochemistry?

For successful immunohistochemical detection of TEK:

• Tissue preparation: Most TEK antibodies work best with frozen sections or Triton-treated sections. Some antibodies are not suitable for paraffin-embedded sections .

• Antigen retrieval: This step is critical for proper epitope exposure:

  • Heat-induced epitope retrieval (HIER) is generally recommended for most tissue types

  • Fixation during paraffinization can cross-link proteins and mask epitopes, resulting in weak or false negative staining

• Dilution optimization:

  • For antibody #37274, a dilution of 1/50 has been validated for paraffin-embedded human thyroid cancer and liver cancer tissues

  • Always perform titration experiments to determine optimal concentration for your specific tissue

• Controls: Include both positive and negative controls to validate antibody specificity

• Visualization: Most TEK antibodies are unconjugated and require appropriate secondary antibodies and detection systems

How should I approach Western blotting with TEK antibodies for optimal results?

For Western blot applications with TEK antibodies:

• Sample preparation: RIPA lysates from endothelial cells (e.g., HUVEC) have been successfully used for TEK detection

• Recommended dilutions:

  • Typically 1:500-1:1000 for most TEK polyclonal antibodies

  • For monoclonal antibodies, follow manufacturer's recommendation (usually 0.2-1 μg/mL)

• Expected molecular weight: TEK protein has a calculated molecular weight of approximately 125.8 kDa , but actual observed weight may vary due to:

  • Post-translational modifications

  • Splice variants

  • Multimers

  • Gel migration differences

• Blocking: Use appropriate blocking reagents to minimize background

• Membranes: PVDF or nitrocellulose membranes are both suitable, but may require different optimization strategies

How can I validate TEK antibody specificity and performance?

Thorough validation is essential for confident interpretation of results:

• Positive controls: Use tissues or cell lines known to express TEK:

  • HUVEC cells for human TEK studies

  • Thyroid or liver cancer tissues for IHC applications

  • Consult databases like Uniprot, Omnigene, and GeneCards for tissues/cell lines with high TEK expression

• Knockout/knockdown controls: If available, use TEK knockout or knockdown samples as negative controls

• Blocking peptide: Use the immunogen peptide to confirm specificity:

  • For recombinant fusion protein immunogens, the blocking peptide may be available from the manufacturer

  • Pre-incubation with the blocking peptide should abolish specific signal

• Cross-reactivity assessment: Perform pair-wise sequence alignment through NCBI-BLAST to predict potential cross-reactivity with other proteins

• Literature validation: Check if the antibody has been published in peer-reviewed literature for your application

Why might I observe inconsistent or unexpected results with TEK antibodies?

Common issues and solutions:

• Band size discrepancies in Western blot:

  • Post-translational modifications (glycosylation, phosphorylation)

  • Splice variants

  • Proteolytic processing

  • Non-specific binding or degradation

• Weak or absent signal in IHC:

  • Inadequate antigen retrieval

  • Overfixation

  • Suboptimal antibody concentration

  • Target protein denaturation

  • Low endogenous expression levels

• High background:

  • Insufficient blocking

  • Excessive antibody concentration

  • Cross-reactivity with similar epitopes

  • Inappropriate secondary antibody

• Batch-to-batch variability:

  • Lot number is typically found under the barcode on antibody vials

  • Always record lot numbers and perform new validation with different lots

How can phospho-specific TEK antibodies advance signaling pathway research?

Phospho-specific TEK antibodies enable detailed investigation of TEK signaling dynamics:

Available phospho-specific antibodies target various sites:

• Anti-TIE2 (phospho Tyr1108)

• Anti-TIE2 (phospho Tyr1102)

• Anti-TIE2 (Phospho-Ser1119)

• Anti-TIE2 (Phospho-Tyr992)

Methodological approaches:

• Temporal analysis: Track phosphorylation changes following stimulation with angiopoietin-1

• Spatial mapping: Combine with subcellular fractionation to determine localization of activated receptors

• Pathway crosstalk: Use multiple phospho-specific antibodies to map interconnected signaling events

• Inhibitor studies: Evaluate pathway-specific inhibitors by monitoring phosphorylation status

Research has identified specific TIE2 cleavage sites relevant to sepsis, pointing to potential therapeutic modulation opportunities .

What are the recent advances in computational approaches to antibody development relevant to TEK research?

Recent computational advances are transforming antibody development:

• Deep learning models:

  • Wasserstein Generative Adversarial Network with Gradient Penalty (WGAN+GP) has been used to generate antibody variable region sequences with high "medicine-likeness"

  • These methods can create antibodies with desirable developability attributes without requiring animal immunization or display technologies

• Experimental validation of in-silico generated antibodies:

  • In a recent study, 51 computationally generated antibodies were tested in two independent laboratories

  • Results showed high expression, monomer content, and thermal stability

  • Low hydrophobicity, self-association, and non-specific binding were observed

• Performance comparison:

  Metric	In-silico Generated Antibodies	Clinical/Marketed Antibodies	p-value	Reference
  Production titer	Higher	Lower	Statistically significant
  Purity	Slightly higher	Lower	Less significant
  Thermal stability	Nearly identical	Similar	0.983
  Hydrophobicity	Similar	Similar	Not significant

• Benefits for TEK research:

  • Potential to develop TEK-specific antibodies with optimized developability profiles

  • Expansion of the "druggable" TEK epitope space

  • Acceleration of discovery timelines for new TEK-targeting therapeutics

What are the optimal storage conditions for maintaining TEK antibody activity?

Proper storage is critical for antibody longevity and performance:

• Temperature: Store at -20°C in the original tube as recommended by most manufacturers

  • Many antibodies are stored in 50% glycerol, which prevents freezing at -20°C

  • For short-term storage (up to one month), 4°C may be suitable

• Aliquoting:

  • Aliquoting is generally unnecessary for -20°C storage and not recommended for glycerol-containing antibodies

  • If frequent use is expected, consider small working aliquots to minimize freeze-thaw cycles

• Freeze-thaw cycles: Avoid repeated freeze-thaw cycles as they can degrade antibody performance

• Shelf life:

  • Manufacturers typically guarantee antibodies for 1 year after purchase

  • Internal studies show that properly stored antibodies remain functional for at least 5 years

• Buffer considerations:

  • Most TEK antibodies are provided in PBS with preservatives like sodium azide and stabilizers like glycerol

  • Typical formulation: 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2

How does antibody concentration affect experimental design with TEK antibodies?

Understanding concentration impacts experimental planning and interpretation:

• Finding concentration information:

  • Check the product datasheet and product vial tube

  • If discrepancies exist between vial and datasheet, refer to the vial concentration

  • Concentration measurement methods vary (Bradford assay vs. Nanodrop), which may affect reported values

• Concentration ranges for common TEK antibodies:

  • Typical concentration range: 1-1.6 mg/ml

  • Dilution factors must be adjusted based on starting concentration

• Methodological implications:

  • Higher concentration antibodies may require greater dilution

  • When comparing results across different antibody lots or sources, normalize for concentration differences

  • For quantitative applications, consider creating standard curves with known concentrations

• Dilution calculations:

  • For a 1 mg/ml antibody requiring 1:500 dilution:

    • 1 μl antibody + 499 μl buffer = 2 μg/ml working solution

  • Always document both the starting concentration and dilution factor

How can TEK antibodies contribute to understanding vascular diseases and therapeutic development?

TEK/TIE2 research has significant clinical implications:

• Venous malformations:

  • Defects in TEK are associated with inherited venous malformations

  • TEK antibodies enable characterization of mutations and signaling alterations

• Angiogenesis in cancer:

  • TEK detection in thyroid and liver cancer tissues has been demonstrated

  • Antibodies enable study of tumor vasculature and potential therapeutic targeting

• Sepsis research:

  • Identification of specific TEK cleavage sites in experimental sepsis models

  • Potential for therapeutic modulation based on these findings

• Stem cell biology:

  • TEK-expressing hematopoietic stem cells (HSCs) show distinct properties:

    • Quiescent and antiapoptotic

    • Comprise a side population that adheres to osteoblasts in bone marrow niches

  • TEK antibodies facilitate isolation and characterization of these specialized stem cells

• Methodological approaches:

  • Flow cytometry with TEK antibodies for cellular phenotyping

  • Immunoprecipitation to study TEK protein interactions

  • Combined with genetic approaches (CRISPR, siRNA) to validate pathways

What technical considerations should be addressed when developing novel assays with TEK antibodies?

When developing new TEK antibody-based assays:

• Epitope mapping:

  • Different antibodies target distinct regions of TEK:

    • Internal residues

    • C-terminal regions (AA 758-789)

    • Specific phosphorylation sites (Tyr992, Tyr1102, Tyr1108, Ser1119)

  • Epitope accessibility varies by application and sample preparation method

• Multiplexed detection:

  • Combining TEK antibodies with markers for other signaling pathways

  • Requirements for compatible species, isotypes, and fluorophores

  • Validation of antibody performance in multiplexed settings

• Emerging technologies:

  • Single-cell applications require highly specific, sensitive antibodies

  • Mass cytometry (CyTOF) requires metal-conjugated antibodies

  • Spatial biology applications demand antibodies compatible with tissue clearing and 3D imaging

• Validation strategies:

  • Orthogonal validation using multiple antibody clones

  • Correlation with genetic expression data

  • Functional validation through pathway modulation

• Reproducibility considerations:

  • Document all antibody details including catalog number, lot, dilution

  • Standardize protocols with detailed methods sections

  • Consider using research resource identifiers (RRIDs) for antibodies in publications

By addressing these considerations, researchers can develop robust, reproducible assays that advance our understanding of TEK biology and its role in health and disease.